Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement

被引:94
作者
Austin, Peter C. [1 ,2 ,3 ]
Fine, Jason P. [4 ,5 ]
机构
[1] Inst Clin Evaluat Sci, G106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Inst Hlth Management Policy & Evaluat, Toronto, ON, Canada
[3] Sunnybrook Res Inst, Schulich Heart Res Program, Toronto, ON, Canada
[4] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[5] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC USA
基金
加拿大健康研究院;
关键词
competing risks; randomized controlled trial; RCT; survival analysis; systematic review; CLINICALLY USEFUL MEASURES; CUMULATIVE INCIDENCE; REGRESSION-MODELS; KAPLAN-MEIER; TREAT; TIME; HAZARDS;
D O I
10.1002/sim.7215
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In studies with survival or time-to-event outcomes, a competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. Specialized statistical methods must be used to analyze survival data in the presence of competing risks. We conducted a review of randomized controlled trials with survival outcomes that were published in high-impact general medical journals. Of 40 studies that we identified, 31 (77.5%) were potentially susceptible to competing risks. However, in the majority of these studies, the potential presence of competing risks was not accounted for in the statistical analyses that were described. Of the 31 studies potentially susceptible to competing risks, 24 (77.4%) reported the results of a Kaplan-Meier survival analysis, while only five (16.1%) reported using cumulative incidence functions to estimate the incidence of the outcome over time in the presence of competing risks. The former approach will tend to result in an overestimate of the incidence of the outcome over time, while the latter approach will result in unbiased estimation of the incidence of the primary outcome over time. We provide recommendations on the analysis and reporting of randomized controlled trials with survival outcomes in the presence of competing risks. (C) 2017 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.
引用
收藏
页码:1203 / 1209
页数:7
相关论文
共 24 条
[1]   Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[2]   Developing points-based risk-scoring systems in the presence of competing risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
D'Agostino, Ralph B. ;
Fine, Jason P. .
STATISTICS IN MEDICINE, 2016, 35 (22) :4056-4072
[3]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[4]   A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals [J].
Austin, Peter C. ;
Manca, Andrea ;
Zwarenstein, Merrick ;
Juurlink, David N. ;
Stanbrook, Matthew B. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (02) :142-153
[5]  
Cook T., 2008, INTRO STAT METHODS C
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
Cox DR., 1984, ANAL SURVIVAL DATA
[8]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[9]   Number needed to treat for time-to-event data with competing risks [J].
Gouskov, Natalia A. ;
Kundu, Suprateek ;
Imrey, Peter B. ;
Fine, Jason P. .
STATISTICS IN MEDICINE, 2014, 33 (02) :181-192
[10]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154